Recent developments in myelofibrosis
Raoul Tibes, James M Bogenberger, Ruben A MesaDivision of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USAAbstract: The myeloproliferative neoplasm of myelofibrosis (MF) is clinically constituted by individuals both with primary MF, as well as those that evolved from an antecedent polycythe...
Enregistré dans:
Auteurs principaux: | Mesa RA, Bogenberger JM, Tibes R |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/080eaffa2590496f87c9e93a7f5c44ed |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Ruxolitinib as an emerging treatment in myelofibrosis
par: Emanuel RM, et autres
Publié: (2013) -
Coexistence of primary myelofibrosis and chronic lymphocytic leukemia
par: Burgstaller S, et autres
Publié: (2014) -
NEXT GENERATION SEQUENCING PRACTICES IN HEMATOLOGY: A RECENT EXPERIENCE OF A SINGLE CENTER
par: Muruvvet Seda AYDIN, et autres
Publié: (2021) -
Therapeutic developments in acute lymphoblastic leukemia
par: MacKenzie A, et autres
Publié: (2012) -
Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase
par: Farina F, et autres
Publié: (2014)